0001214659-20-007795.txt : 20200911 0001214659-20-007795.hdr.sgml : 20200911 20200911161339 ACCESSION NUMBER: 0001214659-20-007795 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200909 FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THORBURN JAMES M CENTRAL INDEX KEY: 0001252038 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 201171082 MAIL ADDRESS: STREET 1: C/O ZILOG INC STREET 2: 532 RACE STREET CITY: SAN JOSE STATE: CA ZIP: 95126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-49661.xml PRIMARY DOCUMENT X0306 4 2020-09-09 0001581280 Twist Bioscience Corp TWST 0001252038 THORBURN JAMES M C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false Chief Financial Officer Common Stock 2020-09-09 4 M false 20000 26.66 A 71719 D Common Stock 2020-09-09 4 S false 18000 65.9042 D 53719 D Common Stock 2020-09-09 4 S false 2000 66.4243 D 51719 D Employee Stock Option (right to buy) 26.66 2020-09-09 4 M false 20000 0 D 2028-11-18 Common Stock 20000 60415 D Represents the weighted average sales price per share. The shares sold at prices ranging from $65.37 to $66.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $66.37 to $66.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. The option is immediately exercisable. 20% of the shares subject to the option vested on October 31, 2019, and 1/60th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. /s/ William Solis, as Attorney-in-Fact for James M. Thorburn 2020-09-11